Author

B. K. Podell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

S. K. Cooper· 2 shared A. A. Bauman· 1 shared A. Fox· 1 shared A. Obregon-Henao· 1 shared B. R. Karger· 1 shared C. Dide-Agossou· 1 shared D. Ackart· 1 shared D. B. Moody· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. K. Cooper

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Establishment of CD1b-restricted immunity to lipid antigens in the pulmonary response to Mycobacterium tuberculosis infection

M. C. Harris, H. E. Gary, S. K. Cooper, D. Ackart, J. E. DiLisio, R. J. Basaraba, T.-Y. Cheng, I. van Rhijn, D. B. Moody, B. K. Podell

This study investigates CD1b-restricted immunity to Mycobacterium tuberculosis in guinea pigs, showing transient CD1b upregulation during infection and its role in pulmonary and extrapulmonary immune responses.

bioRxiv · May 23, 2023 · PreprintImmunology

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

N. D. Walter, J. P. Ernest, C. Dide-Agossou, A. A. Bauman, M. E. Ramey, K. Rossmassler, L. M. Massoudi, S. Pauly, R. Al Mubarak, M. I. Voskuil, F. Kaya, J. P. Sarathy, M. D. Zimmerman, V. Dartois, B. K. Podell, , G. T. Robertson

The paper shows that Mycobacterium tuberculosis in different lung microenvironments have distinct phenotypes and treatment responses in a mouse model.

bioRxiv · Feb 3, 2023 · PreprintMicrobiology

A Whole Virion Vaccine for COVID-19 Produced Via a Novel Inactivation Method: Results from Animal Challenge Model Studies

I. K. Ragan, L. M. Hartson, T. S. Dutt, A. Obregon-Henao, R. M. Maison, P. Gordy, A. Fox, B. R. Karger, S. T. Cross, M. L. Kapuscinski, S. K. Cooper, B. K. Podell, M. D. Stenglein, R. A. Bowen, M. Henao-Tamayo, R. Goodrich

This paper evaluates a novel inactivated whole virion COVID-19 vaccine (SolaVAX) in hamsters, showing its ability to induce neutralizing antibodies and protect against SARS-CoV-2 infection.

bioRxiv · Nov 13, 2020Immunology